Position in ZTS
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$3,736
+$3,145 QoQ
Shares Held
52
+940.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,306
of 1,408 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Hughes Financial Services, LLC holds $65,845 across 20 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PAHC |
Phibro Animal Health Corp
|
858 | $26,941 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
34 | $18,422 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
36 | $6,067 | |
| 4 | VTRS |
Viatris Inc
|
339 | $5,383 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
52 | $3,736 | |
| 6 | TAK |
Takeda Pharmaceutical Co Ltd
|
145 | $2,324 | |
| 7 | ETON |
Eton Pharmaceuticals, Inc.
|
33 | $1,194 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
16 | $393 |
All Filings in ZTS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,736 | 52 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $591 | 5 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $251 | 2 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,755 | 12 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $935 | 6 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $4,280 | 26 | Shares | Sole | 2025-05-01 | |
| No filing history on record for this holder in this stock. | ||||||